TOP
background img

Background Of Sino Harbour

Sino Harbour Holdings Group Limited (the “Group”),former named Sino Harbour Property Group Limited, is a property developer focused on the second and third tire cities in the P.R.C., the headquartered is in Hong Kong. The Group’s parent company – Pan Hong Holdings Group Limited (SGX:P36) (“Pan Hong Group”) listed on Singapore Stock Exchange in 2006, has more than 20 years of property development experience in niche markets within China. Pan Hong Group spun off the Group in 2011 to further expand its business. While the Group is currently principally engaged in the business of property development, it has been exploring and seeking new opportunities to broaden revenue and improve profitability. To efforts being made in diversifying the Group’s business and better reflect or align with the business nature and principal activity of the Group, the Group change its name to Sino Harbour Holdings Group Limited from Sino Harbour Property Group Limited with effect from 24th August 2015. The Group is currently expanding the pharmaceutical inspection business and further to the stem cell industry.

Competitive Advantage

Capturing the potential of Central China

To efforts being made in diversify of our business, Sino Harbour is expanding its business activity......

Capturing the potential of Central China

To efforts being made in diversify of our business, Sino Harbour is expanding its business activity to Healthcare Industry and focus on pharmaceutical inspection and stem cell markets, we are expected to be an inspection expert and stem cell expert as the middle and long term targets. Sino Harbour will take to improve human life and health as our mission to become a respectable enterprise in future.

Experienced management team

In the field of pharmaceutical inspection, Irvine Pharmaceutical Services Inc., a reputable......

Experienced management team

In the field of pharmaceutical inspection, Irvine Pharmaceutical Services Inc., a reputable pharmaceutical development and manufacturing company, is our comprehensive strategic partners. Moreover, the team comprising of domestic and foreign stem cells experts will lead us to enter into stem cells industry.

The chairlady and deputy chairman of Sino Harbour have about 20 years of experience in property development in PRC. Leading the Group’s development and with foresight, they lead the enterprise to enter into a new health industry.

Focusing on development of property projects in Jiangxi Province, the P.R.C.

Benefiting from the increasing job opportunities and improving of residents’ quality of life, the demand for the residential properties in.......

Focusing on development of property projects in Jiangxi Province, the P.R.C.

Benefiting from the increasing job opportunities and improving of residents’ quality of life, the demand for the residential properties in Jiangxi Province is growing.Furthermore, the living of expenses in Jiangxi Province is lower comparing with other cities and provinces, moreover, national railway systems and transportation networks in P.R.C. are maturing, enhancing Jiangxi Province becomes more attractive to those people who demand for a better quality of life, which benefit the residential property market in the Jiangxi Province.

Transition Progress

2015.12.15

The Group’s subsidiary, Sino Harbour Bio Technology Limited signs a joint venture agreement, in order to enter the pharmaceutical inspection industry.

2015.10.06

The Company changed its name to Sino Harbour Holdings Group Limited, which confirms the Company’s transition direction.

2015.08.03

Sino Harbour Bio Technology Limited was established, to engage in the business of health.

2015.07.22

Sino Harbour Bio Technology Holdings Group Limited established, to engage in the business of health.

2016.02.22

The Group’s subsidiary, Sino Harbour Bio Technology Limited signed a strategic cooperation framework agreement to enter the stem cell industry.

2015.11.27

The Group’s subsidiary, Jiangxi Asia City Real Estate Development Company Limited signed an agreement to subscribe for the 30% equity interest in Zhejiang Davi Pharmaceutical Co., Ltd.

2015.10.06

The Group’s subsidiary, Sino Harbour Bio Technology Limited signed a strategic cooperation framework agreement to enter into the industry of pharmaceutical inspection.

2015.07.28

Jiangxi Hanyun Incubator Limited established, to assists the Group to seek suitable investment.